Vera Imperiale
Psychiatric/Mental Health · Albany, NYNPI 1699890095
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $50,325 of the $69,141 with a category attached, or 72.8%. 26 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 58.0% of the total. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 717 payments — averaging $96.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$40K
- AbbVie$19K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Johnson & Johnson$1K
- Neurocrine Biosciences, Inc.$890
- Axsome Therapeutics, Inc.$824
- plus $5K from 20 others
What the payments were for
- Speaking & faculty fees$50,32573%
- Travel & lodging$2,8214%
- Food & beverage$15,99523%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 105 | $40,118 |
| AbbVie(2 entities) | 158 | $18,586 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 93 | $2,269 |
| Johnson & Johnson | 43 | $1,054 |
| Neurocrine Biosciences, Inc. | 38 | $890 |
| Axsome Therapeutics, Inc. | 38 | $824 |
| Takeda Pharmaceuticals U.S.A., Inc. | 43 | $793 |
| Corium, LLC | 29 | $710 |
| Lundbeck LLC | 30 | $658 |
| Alkermes, Inc. | 24 | $619 |
| Otsuka America Pharmaceutical, Inc. | 19 | $466 |
| Teva Pharmaceuticals USA, Inc. | 15 | $414 |
| Vanda Pharmaceuticals Inc. | 19 | $366 |
| Ironshore Pharmaceuticals Inc. | 14 | $330 |
| E.r. Squibb & Sons, L.L.C. | 13 | $277 |
| Novo Nordisk | 4 | $185 |
| Sunovion Pharmaceuticals Inc. | 11 | $157 |
| Idorsia Pharmaceuticals US Inc | 6 | $117 |
| Collegium Pharmaceutical, Inc. | 4 | $93 |
| Eisai Inc. | 3 | $59 |
| Bausch Health US, LLC | 2 | $47 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Almatica Pharma LLC | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Biogen | 1 | $18 |
| Neuronetics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$69,141 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $95,834 |
| VraylarCariprazine Hcl | 38 | $54,573 |
| RexultiBrexpiprazole | 28 | $41,966 |
| CaplytaLumateperone Tosylate | 12 | $19,170 |
| Aripiprazole | 149 | $8,459 |
| TrintellixVortioxetine Hydrobromide | 17 | $7,878 |
| Clomipramine Hcl | 22 | $5,009 |
| Methylphenidate ErMethylphenidate Hcl | 19 | $3,812 |
| Bupropion XlBupropion Hcl | 170 | $3,670 |
| Duloxetine Hcl | 224 | $3,506 |
| Quetiapine Fumarate | 206 | $3,115 |
| Lurasidone Hcl | 74 | $2,761 |
| Olanzapine | 118 | $2,640 |
| Alprazolam | 186 | $2,601 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 173 | $2,501 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $890 | $95,83411 claims |
| AbbVieVraylar | $18,586 | $54,57338 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $466 | $41,96628 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $2,269 | $19,17012 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $793 | $7,87817 claims |
| Almatica Pharma LLCSertraline Hcl | $21 | $861151 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Other psychiatric/mental health in Albany
- Patricia MuttererAlbany$18K
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
- Alexis CrisafiFishkill$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.